The South Amerindian allotype HLA-B*3909 has the largest known similarity in peptide specificity and common natural ligands with HLA-B27

Tissue Antigens

Volumn 53, Issue 3, 1999, Pages 227-236

  Yague J ^a   Ramos, M ^a   Vazquez J ^a   Marina, A ^a   Albar, J P ^b   López de Castro, José A ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

B*3909; HLA polymorphism; HLA B27; HLA B39; Mass spectrometry; Peptide motifs; Peptides

Indexed keywords

ARGININE; HISTAMINE; HLA B ANTIGEN; HLA B27 ANTIGEN;

ALLOTYPE; AMERICAN INDIAN; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SOUTH AMERICA; SPONDYLOARTHROPATHY;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CELL LINE; FLOW CYTOMETRY; HLA-B ANTIGENS; HLA-B27 ANTIGEN; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; TRANSFECTION;

EID: 0033029388     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530302.x     Document Type: Article

References (39)

1. Belich MP, Madrigal JA, Hildebrand WH et al. Unusual HLA-B alleles in two tribes of Brazilian Indians. Nature 1992: 357: 326-9.
2. Watkins DI, McAdam SN, Liu X et al. New recombinant HLA-B alleles in a tribe of South American Amerindians indicate rapid evolution of MHC class I loci. Nature 1992: 357: 329-33.
3. Parham P, Arnett KL, Adams EJ et al. Episodic evolution and turnover of HLA-B in the indigenous human populations of the Americas. Tissue Antigens 1997: 50: 219-32.
4. Fernandez-Vina MA, Lazaro AM, Marcos CY et al. Dissimilar evolution of B-locus versus A-locus and class II loci of the HLA region in South American Indian tribes. Tissue Antigens 1997: 50: 233-50.
5. Cadavid LF, Watkins DI. Heirs of the jaguar and the anaconda: HLA, conquest and disease in the indigenous populations of the Americas. Tissue Antigens 1997: 50: 702-11.
6. Khan MA. Spondyloarthropathies [Editorial]. Curr Opin Rheumatol 1998: 10: 279-81.
7. Falk K, Rotzschke O, Takiguchi M et al. Peptide motifs of HLA-B38 and B39 molecules. Immunogenetics 1995: 41: 162-4.
8. Sobao Y, Tsuchiya N, Takiguchi M, Tokunaga K. Overlapping peptide-binding specificities of HLA-B27 and B39. Evidence for a role of peptide supermotif in the pathogenesis of spondylarthropathies. Arthritis Rheum 1999: 42: 175-81.
9. Yague J, Vazquez J, López de Castro JA. A single amino acid change makes the peptide specificity of B*3910 unrelated to B*3901 and closer to a group of HLA-B proteins including the malaria-protecting allotype HLA-B53. Tissue Antigens 1998: 52: 416-21.
10. Ramos M, Postigo JM, Vilches C, Layrisse Z, López de Castro JA. Primary structure of a novel HLA-B39 allele (B*3909) from the Warao Indians of Venezuela. Further evidence for local HLA-B diversification in South America. Tissue Antigens 1995: 46: 401-4.
11. Calvo V, Rojo S, Lopez D, Galocha B, López de Castro JA. Structure and diversity of HLA-B27-specific T cell epitopes. Analysis with site-directed mutants mimicking HLA-B27 subtype polymorphism. J Immunol 1990: 144: 4038-45.
12. Villadangos JA, Galocha B, Garcia F, Albar JP, López de Castro JA. Modulation of peptide binding by HLA-B27 polymorphism in pockets A and B, and peptide specificity of B*2703. Eur J Immunol 1995: 25: 2370-7.
13. Villadangos JA, Galocha B, López de Castro JA. Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity. J Immunol 1994: 152: 2317-23.
14. Barnstable CJ, Bodmer WF, Brown G et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens. New tools for genetic analysis. Cell 1978: 14: 9-20.
15. Ellis SA, Taylor C, McMichael A. Recognition of HLA-B27 and related antigens by a monoclonal antibody. Hum Immunol 1982: 5: 49-59.
16. Garcia F, Marina A, López de Castro JA. Lack of carboxyl-terminal tyrosine distinguishes the B*2706-bound peptide repertoire from those of B*2704 and other HLA-B27 subtypes associated to ankylosing spondylitis. Tissue Antigens 1997: 49: 215-21.
17. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991: 351: 290-6.
18. Paradela A, Garcia-Peydro M, Vazquez J, Rognan D, López de Castro JA. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: role of peptide and the MHC molecule in alloreactivity. J Immunol 1998: 161: 5481-90.
19. Wilm M, Mann M. Analytical properties of the nanoelectrospray ion source. Anal Chem 1996: 68: 1-8.
20. Marina A, Garcia MA, Albar JP, Yague J, López de Castro JA, Vazquez J. High sensitivity analysis and sequencing of peptides and proteins by quadrupole ion trap mass spectrometry. J Mass Spectrom 1998: in press.
21. Galocha B, Lamas JR, Villadangos JA, Albar JP, López de Castro JA. Binding of peptides naturally presented by HLA-B27 to the differentially disease-associated B*2704 and B*2706 subtypes, and to mutants mimicking their polymorphism. Tissue Antigens 1996: 48: 509-18.
22. Rotzschke O, Falk K, Stevanovic S, Gnau V, Jung G, Rammensee HG. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs. Immunogenetics 1994: 39: 74-7.
23. Garcia F, Galocha B, Villadangos JA et al. HLA-B27 (B*2701) specificity for peptides lacking Arg2 is determined by polymorphism outside the B pocket. Tissue Antigens 1997: 49: 580-7.
24. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 1991: 219: 277-319.
25. Crivellato E, Zacchi T. HLA-B39 and the axial type of psoriatic arthritis. Acta Derm Venereol 1987: 67: 249-50.
26. Gladman DD, Farewell VT. The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum 1995: 38: 845-50.
27. Yamaguchi A, Tsuchiya N, Mitsui H et al. Association of HLA-B39 with HLA-B27-negative ankylosing spondylitis and pauciarticular juvenile rheumatoid arthritis in Japanese patients. Evidence for a role of the peptide-anchoring B pocket. Arthritis Rheum 1995: 38: 1672-7.
28. Barber LD, Percival L, Parham P. Characterization of the peptide-binding specificity of HLA-B*7301. Tissue Antigens 1996: 47: 472-7.
29. Gomard E, Sitbon M, Toubert A, Begue B, Levy JP. HLA-B27, a dominant restricting element in antiviral responses? Immunogenetics 1984: 20: 197-204.
30. Kaslow RA, Carrington M, Apple R et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996: 2: 405-11.
31. McNeil AJ, Yap PL, Gore SM et al. Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. Q J Med 1996: 89: 177-85.
32. Goulder PJ, Phillips RE, Colbert RA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997: 3: 212-7.
33. Jardetzky TS, Lane WS, Robinson RA, Madden DR, Wiley DC. Identification of self peptides bound to purified HLA-B27. Nature 1991: 353: 326-9.
34. Boisgérault F, Tieng V, Stolzenberg MC et al. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: implications for susceptibility to spondylarthropathies. J Clin Invest 1996: 98: 2764-70.
35. Brooks JM, Murray RJ, Thomas WA, Kurilla MG, Rickinson AB. Different HLA-B27 subtypes present the same immunodominant Epstein-Barr virus peptide. J Exp Med 1993: 178: 879-87.
36. Lamas JR, Brooks JM, Galocha B, Rickinson AB, López de Castro JA. Relationship between peptide binding and T cell epitope selection: a study with subtypes of HLA-B27. Int Immunol 1998: 10: 259-66.
37. Garcia F, Rognan D, Lamas JR, Marina A, López de Castro JA. An HLA-B27 polymorphism (B*2710) that is critical for T-cell recognition has limited effects on peptide specificity. Tissue Antigens 1998: 58: 1-9.
38. Roepstorff P, Fohlman J. Proposal for a common nomenclature for sequence ions in mass spectra of peptides [Letter]. Biomed Mass Spectrom 1984: 11: 601.
39. Martinez-Arends A, Layrisse Z, Argüello R et al. Characterization of the HLA class I genotypes of a Venezuelan Amerindian group by molecular methods. Tissue Antigens 1998: 52: 51-6.